| Literature DB >> 24037107 |
Lina Marcela Villa1, Felipe Guhl, Daniel Zabala, Juan David Ramírez, Daniel Alfonso Urrea, Diana Carolina Hernández, Zulma Cucunubá, Marleny Montilla, Julio César Carranza, Karina Rueda, Jorge Eduardo Trujillo, Gustavo Adolfo Vallejo.
Abstract
A single polymerase chain reaction (PCR) reaction targeting the spliced-leader intergenic region of Trypanosoma cruzi I was standardised by amplifying a 231 bp fragment in domestic (TcIDOM) strains or clones and 450 and 550 bp fragments in sylvatic strains or clones. This reaction was validated using 44 blind coded samples and 184 non-coded T. cruzi I clones isolated from sylvatic triatomines and the correspondence between the amplified fragments and their domestic or sylvatic origin was determined. Six of the nine strains isolated from acute cases suspected of oral infection had the sylvatic T. cruzi I profile. These results confirmed that the sylvatic T. cruzi I genotype is linked to cases of oral Chagas disease in Colombia. We therefore propose the use of this novel PCR reaction in strains or clones previously characterised as T. cruzi I to distinguish TcIDOMfrom sylvatic genotypes in studies of transmission dynamics, including the verification of population selection within hosts or detection of the frequency of mixed infections by both T. cruzi I genotypes in Colombia.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24037107 PMCID: PMC3970654 DOI: 10.1590/0074-0276130201
Source DB: PubMed Journal: Mem Inst Oswaldo Cruz ISSN: 0074-0276 Impact factor: 2.743
Fig. 1:Lanes 1-14 in A and B contain the same Trypanosoma cruzi I strains or clones. A: differentiation between Trypanosoma cruzi I and T. cruzi II using TCC/TC1/TC2 primers (Souto et al. 1996). 1-14: T. cruzi I (350 bp); 15: T. cruzi II (300 bp); M: 100 bp ladder; 1: MHOM/C0/04/MG strain; 2: CG clone 1; 3: ORT15 Rcol strain; 4: Rcol clone 03; 5: Rpal clone 139-2; 6: Rpal clone 89-2; 7: Rpro (sylvatic) clone 8; 8: Rpro (sylvatic) clone 10; 9: D1 ( Didelphis ) strain; 10: D2 ( Didelphis ) strain; 11: X1081 Rpro (domestic) strain; 12: X1082 Rpro (domestic) strain; 13: CG clone 13; 14: EH strain; 15: T. cruzi II (300 bp); B: genotyping T. cruzi I strains and clones using a single pair of primers (1Am/1B) designed in the spliced-leader intergenic region. Domestic strains were identified by amplifying a 231 bp fragment and sylvatic strains were identified by amplifying a 450-550 bp fragment. M: 100 bp ladder; 1: MHOM/C0/04/MG strain; 2: CG clone 1; 3: ORT15 Rcol strain; 4: Rcol clone 03; 5: Rpal clone 139-2; 6: Rpal clone 89-2; 7: Rpro (sylvatic) clone 8; 8: Rpro (sylvatic) clone 10; 9: D1 ( Didelphis ) strain; 10: D2 ( Didelphis ) strain; 11: X1081 Rpro (domestic) strain; 12: X1082 Rpro (domestic) strain; 13: CG clone 13; 14: EH strain; M: 100 bp ladder.
Fig. 2characterisation of human isolates using 1Am/1B primers. Lanes 1-2 contain the same samples of MHOM/CO/03/CG C1 clone of human origin and Lanes 3-8 contain the strains SMA, XCH, JEM, YLY, EH, HMriv isolated from acute cases of Chagas disease in Colombia.